Tag #Pbm

Showing 1 to 2 of 2 results

forbes.com
🌐 85% Global Worthiness
News related image

CVS Drops Eli Lilly's Zepbound from Preferred Formulary

CVS Health will remove Eli Lilly's weight-loss drug Zepbound from its preferred formulary starting July 1, 2025, prioritizing Novo Nordisk's Wegovy; this impacts 90 million CVS Caremark members and highlights the power of PBMs in shaping drug access and affordability.

Progress

36% Bias Score

Good Health and Well-being
forbes.com
🌐 75% Global Worthiness
News related image

Walgreens Considers Breakup, Bucking Healthcare Consolidation Trend

Walgreens Boots Alliance is considering splitting into three companies: Boots UK, U.S. retail pharmacies, and a specialty pharmacy, diverging from the healthcare consolidation trend exemplified by CVS Health's integrated model. This follows Walgreens' financial losses and struggles with its VillageM...

Progress

48% Bias Score

Good Health and Well-being

Showing 1 to 2 of 2 results